Document is current
Any future updates will be listed below
-
Authors
Liu, Yingzi https://orcid.org/0000-0002-8704-4756
Tosti, Antonella https://orcid.org/0000-0001-5516-4043
Wang, Etienne C. E.
Heilmann-Heimbach, Stefanie
Aguh, Crystal
Jimenez, Francisco
Lin, Sung-Jan https://orcid.org/0000-0003-1325-3464
Kwon, Ohsang https://orcid.org/0000-0003-0464-5124
Plikus, Maksim V. https://orcid.org/0000-0002-8845-2559
- License Information
-
More Information
Article History
Accepted: 4 September 2025
First Online: 9 October 2025
Competing interests
: M.V.P. and Y.L. are inventors on patent applications related to hair loss treatment filed by the University of California, Irvine. M.V.P. is co-founder and Chief Scientific Officer at the Amplifica Holdings Group, Inc., and has received consultation fees from Oddity Labs and L’Oréal. A.T. has received consultation fees from DS Laboratories, Almirall, Thirty Madison, Eli Lilly and Company, Pfizer, Myovant Sciences, Bristol Myers Squibb, Ortho Dermatologics and Sun Pharmaceutical. C.A. has received consultation fees from Eli Lilly and Company, Pfizer, Olaplex and Myovant Sciences; has authored an UpToDate section on central centrifugal cicatricial alopecia; and directs the Ethnic Skin Program at Johns Hopkins University, funded by an educational grant from Janssen. S.H.-H. has received salary payments from Life & Brain GmbH. S.-J.L. has received clinical trial funds from Eli Lilly and Company. O.K. has received consultation fees from Eli Lilly and Company and has received clinical study funds from Eli Lilly and Company, Pfizer and AbbVie. E.C.E.W. and F.J. declare no competing interests.
